Additionally, studies have shown that levels of Eotaxin-1 are associated with metabolic disorders such as insulin resistance, impaired glucose tolerance and abnormal lipid metabolism, which are all risk factors for the development of NAFLD (38). Here, CCL11 is linked to Other metabolic disease.